Literature DB >> 10631552

The initiation of autoimmune diabetes.

E A Green1, R A Flavell.   

Abstract

It is speculated that presentation of self-peptides to autoreactive T cells normally results in T cell tolerance. In autoimmune conditions, breakdown in the tolerization process results in activation of self-reactive T cells and an immune attack on host tissues. Our understanding of the immune cells and signaling pathways that contribute to this breakdown in T cell tolerization mechanisms is beginning to be deciphered. In particular, the elucidation of the mechanisms that contribute to the release of host antigen, the identification of the antigen-presenting cells that present the host peptides to self-reactive T cells and the role of members of the tumor necrosis factor receptor/ligand families that contribute to inappropriate activation of self-reactive T cells is advancing. The accumulating data from these studies will hopefully provide new ideas for combating autoimmunity.

Entities:  

Mesh:

Year:  1999        PMID: 10631552     DOI: 10.1016/s0952-7915(99)00034-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  6 in total

Review 1.  Toxic type 1 diabetes.

Authors:  Mark A Myers; Ian R Mackay; Paul Z Zimmet
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.

Authors:  Woelsung Yi; Nilufer P Seth; Tom Martillotti; Kai W Wucherpfennig; Derek B Sant'Angelo; Lisa K Denzin
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

3.  Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.

Authors:  Helen M McGuire; Stacey Walters; Alexis Vogelzang; Carol M Y Lee; Kylie E Webster; Jonathan Sprent; Daniel Christ; Shane Grey; Cecile King
Journal:  Diabetes       Date:  2011-03       Impact factor: 9.461

Review 4.  Human leukocyte Antigen-DM polymorphisms in autoimmune diseases.

Authors:  Miguel Alvaro-Benito; Eliot Morrison; Marek Wieczorek; Jana Sticht; Christian Freund
Journal:  Open Biol       Date:  2016-08       Impact factor: 6.411

5.  Drug-Integrating Amphiphilic Nanomaterial Assemblies: 1. Spatiotemporal control of cyclosporine delivery and activity using nanomicelles and nanofibrils.

Authors:  Diana Velluto; Damir Bojadzic; Teresa De Toni; Peter Buchwald; Alice A Tomei
Journal:  J Control Release       Date:  2020-10-18       Impact factor: 9.776

6.  Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice.

Authors:  Sabyasachi Chakrabarti; Koichi S Kobayashi; Richard A Flavell; Carolyn B Marks; Katsuya Miyake; David R Liston; Kimberly T Fowler; Fred S Gorelick; Norma W Andrews
Journal:  J Cell Biol       Date:  2003-08-18       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.